Logo image of TECH

BIO-TECHNE CORP (TECH) Stock Fundamental Analysis

NASDAQ:TECH - US09073M1045 - Common Stock

56.9 USD
+2.9 (+5.37%)
Last: 8/22/2025, 1:54:09 PM
Fundamental Rating

5

Overall TECH gets a fundamental rating of 5 out of 10. We evaluated TECH against 54 industry peers in the Life Sciences Tools & Services industry. TECH is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. TECH has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year TECH was profitable.
TECH had a positive operating cash flow in the past year.
TECH had positive earnings in 4 of the past 5 years.
TECH had a positive operating cash flow in 4 of the past 5 years.
TECH Yearly Net Income VS EBIT VS OCF VS FCFTECH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

TECH has a Return On Assets of 4.98%. This is in the better half of the industry: TECH outperforms 77.78% of its industry peers.
With a decent Return On Equity value of 6.52%, TECH is doing good in the industry, outperforming 74.07% of the companies in the same industry.
The Return On Invested Capital of TECH (7.71%) is better than 77.78% of its industry peers.
The Average Return On Invested Capital over the past 3 years for TECH is significantly below the industry average of 15.98%.
Industry RankSector Rank
ROA 4.98%
ROE 6.52%
ROIC 7.71%
ROA(3y)9.62%
ROA(5y)9.27%
ROE(3y)12.87%
ROE(5y)12.83%
ROIC(3y)10.35%
ROIC(5y)9.61%
TECH Yearly ROA, ROE, ROICTECH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a decent Profit Margin value of 10.89%, TECH is doing good in the industry, outperforming 77.78% of the companies in the same industry.
TECH's Profit Margin has improved in the last couple of years.
With an excellent Operating Margin value of 18.05%, TECH belongs to the best of the industry, outperforming 81.48% of the companies in the same industry.
TECH's Operating Margin has been stable in the last couple of years.
With an excellent Gross Margin value of 66.39%, TECH belongs to the best of the industry, outperforming 92.59% of the companies in the same industry.
In the last couple of years the Gross Margin of TECH has remained more or less at the same level.
Industry RankSector Rank
OM 18.05%
PM (TTM) 10.89%
GM 66.39%
OM growth 3Y-6.6%
OM growth 5Y0.54%
PM growth 3Y-1.27%
PM growth 5Y1.52%
GM growth 3Y-0.78%
GM growth 5Y0.03%
TECH Yearly Profit, Operating, Gross MarginsTECH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

TECH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
TECH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TECH Yearly Shares OutstandingTECH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
TECH Yearly Total Debt VS Total AssetsTECH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 9.68 indicates that TECH is not in any danger for bankruptcy at the moment.
TECH has a Altman-Z score of 9.68. This is amongst the best in the industry. TECH outperforms 92.59% of its industry peers.
TECH has a debt to FCF ratio of 1.49. This is a very positive value and a sign of high solvency as it would only need 1.49 years to pay back of all of its debts.
TECH has a Debt to FCF ratio of 1.49. This is amongst the best in the industry. TECH outperforms 85.19% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that TECH is not too dependend on debt financing.
TECH's Debt to Equity ratio of 0.16 is fine compared to the rest of the industry. TECH outperforms 61.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.49
Altman-Z 9.68
ROIC/WACC0.73
WACC10.62%
TECH Yearly LT Debt VS Equity VS FCFTECH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.3 Liquidity

TECH has a Current Ratio of 3.71. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of TECH (3.71) is better than 61.11% of its industry peers.
TECH has a Quick Ratio of 2.58. This indicates that TECH is financially healthy and has no problem in meeting its short term obligations.
With a Quick ratio value of 2.58, TECH perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.71
Quick Ratio 2.58
TECH Yearly Current Assets VS Current LiabilitesTECH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

TECH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.43%, which is quite good.
Measured over the past years, TECH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.25% on average per year.
EPS 1Y (TTM)8.43%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%8.16%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.55%

3.2 Future

The Earnings Per Share is expected to grow by 8.61% on average over the next years. This is quite good.
TECH is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.12% yearly.
EPS Next Y9.98%
EPS Next 2Y11.75%
EPS Next 3Y11.13%
EPS Next 5Y8.61%
Revenue Next Year5.48%
Revenue Next 2Y7.38%
Revenue Next 3Y6.64%
Revenue Next 5Y7.12%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
TECH Yearly Revenue VS EstimatesTECH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
TECH Yearly EPS VS EstimatesTECH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 29.48, which means the current valuation is very expensive for TECH.
Based on the Price/Earnings ratio, TECH is valued a bit cheaper than the industry average as 68.52% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of TECH to the average of the S&P500 Index (26.76), we can say TECH is valued inline with the index average.
The Price/Forward Earnings ratio is 26.81, which means the current valuation is very expensive for TECH.
Based on the Price/Forward Earnings ratio, TECH is valued a bit cheaper than 72.22% of the companies in the same industry.
TECH's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 34.91.
Industry RankSector Rank
PE 29.48
Fwd PE 26.81
TECH Price Earnings VS Forward Price EarningsTECH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, TECH is valued a bit cheaper than 62.96% of the companies in the same industry.
TECH's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. TECH is cheaper than 62.96% of the companies in the same industry.
Industry RankSector Rank
P/FCF 40.41
EV/EBITDA 26.3
TECH Per share dataTECH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates TECH does not grow enough to justify the current Price/Earnings ratio.
The decent profitability rating of TECH may justify a higher PE ratio.
PEG (NY)2.95
PEG (5Y)2.62
EPS Next 2Y11.75%
EPS Next 3Y11.13%

4

5. Dividend

5.1 Amount

With a yearly dividend of 0.60%, TECH is not a good candidate for dividend investing.
TECH's Dividend Yield is rather good when compared to the industry average which is at 0.54. TECH pays more dividend than 94.44% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, TECH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.6%

5.2 History

The dividend of TECH decreases each year by -0.07%.
TECH has been paying a dividend for at least 10 years, so it has a reliable track record.
TECH has decreased its dividend recently.
Dividend Growth(5Y)-0.07%
Div Incr Years0
Div Non Decr Years1
TECH Yearly Dividends per shareTECH Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

TECH pays out 38.46% of its income as dividend. This is a sustainable payout ratio.
DP38.46%
EPS Next 2Y11.75%
EPS Next 3Y11.13%
TECH Yearly Income VS Free CF VS DividendTECH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
TECH Dividend Payout.TECH Dividend Payout, showing the Payout Ratio.TECH Dividend Payout.PayoutRetained Earnings

BIO-TECHNE CORP

NASDAQ:TECH (8/22/2025, 1:54:09 PM)

56.9

+2.9 (+5.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)10-28 2025-10-28/bmo
Inst Owners105.81%
Inst Owner Change-8.22%
Ins Owners0.23%
Ins Owner Change2.66%
Market Cap8.92B
Analysts78.33
Price Target68.1 (19.68%)
Short Float %4.09%
Short Ratio2.91
Dividend
Industry RankSector Rank
Dividend Yield 0.6%
Yearly Dividend0.32
Dividend Growth(5Y)-0.07%
DP38.46%
Div Incr Years0
Div Non Decr Years1
Ex-Date08-18 2025-08-18 (0.08)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.96%
Min EPS beat(2)6.57%
Max EPS beat(2)7.36%
EPS beat(4)3
Avg EPS beat(4)4.72%
Min EPS beat(4)-2.78%
Max EPS beat(4)7.75%
EPS beat(8)4
Avg EPS beat(8)1.1%
EPS beat(12)4
Avg EPS beat(12)-4.03%
EPS beat(16)8
Avg EPS beat(16)-1.78%
Revenue beat(2)1
Avg Revenue beat(2)-0.55%
Min Revenue beat(2)-2.38%
Max Revenue beat(2)1.28%
Revenue beat(4)2
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-2.38%
Max Revenue beat(4)1.28%
Revenue beat(8)3
Avg Revenue beat(8)-1.65%
Revenue beat(12)3
Avg Revenue beat(12)-2.63%
Revenue beat(16)6
Avg Revenue beat(16)-1.67%
PT rev (1m)-3.5%
PT rev (3m)-17.7%
EPS NQ rev (1m)-0.58%
EPS NQ rev (3m)-8.27%
EPS NY rev (1m)0%
EPS NY rev (3m)0.13%
Revenue NQ rev (1m)-0.17%
Revenue NQ rev (3m)-3.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.32%
Valuation
Industry RankSector Rank
PE 29.48
Fwd PE 26.81
P/S 7.38
P/FCF 40.41
P/OCF 33.68
P/B 4.42
P/tB 14.73
EV/EBITDA 26.3
EPS(TTM)1.93
EY3.39%
EPS(NY)2.12
Fwd EY3.73%
FCF(TTM)1.41
FCFY2.47%
OCF(TTM)1.69
OCFY2.97%
SpS7.71
BVpS12.87
TBVpS3.86
PEG (NY)2.95
PEG (5Y)2.62
Profitability
Industry RankSector Rank
ROA 4.98%
ROE 6.52%
ROCE 8.82%
ROIC 7.71%
ROICexc 8.17%
ROICexgc 20.68%
OM 18.05%
PM (TTM) 10.89%
GM 66.39%
FCFM 18.26%
ROA(3y)9.62%
ROA(5y)9.27%
ROE(3y)12.87%
ROE(5y)12.83%
ROIC(3y)10.35%
ROIC(5y)9.61%
ROICexc(3y)11.38%
ROICexc(5y)10.7%
ROICexgc(3y)34.23%
ROICexgc(5y)37.23%
ROCE(3y)11.84%
ROCE(5y)11%
ROICexcg growth 3Y-22.4%
ROICexcg growth 5Y-11.06%
ROICexc growth 3Y-7.28%
ROICexc growth 5Y2.42%
OM growth 3Y-6.6%
OM growth 5Y0.54%
PM growth 3Y-1.27%
PM growth 5Y1.52%
GM growth 3Y-0.78%
GM growth 5Y0.03%
F-Score5
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF 1.49
Debt/EBITDA 1
Cap/Depr 39.78%
Cap/Sales 3.65%
Interest Coverage 13.35
Cash Conversion 80.49%
Profit Quality 167.69%
Current Ratio 3.71
Quick Ratio 2.58
Altman-Z 9.68
F-Score5
WACC10.62%
ROIC/WACC0.73
Cap/Depr(3y)45.44%
Cap/Depr(5y)49.87%
Cap/Sales(3y)4.28%
Cap/Sales(5y)4.92%
Profit Quality(3y)106.47%
Profit Quality(5y)121.17%
High Growth Momentum
Growth
EPS 1Y (TTM)8.43%
EPS 3Y-0.77%
EPS 5Y11.25%
EPS Q2Q%8.16%
EPS Next Y9.98%
EPS Next 2Y11.75%
EPS Next 3Y11.13%
EPS Next 5Y8.61%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%3.55%
Revenue Next Year5.48%
Revenue Next 2Y7.38%
Revenue Next 3Y6.64%
Revenue Next 5Y7.12%
EBIT growth 1Y-33.29%
EBIT growth 3Y0.48%
EBIT growth 5Y10.77%
EBIT Next Year22.61%
EBIT Next 3Y14%
EBIT Next 5Y10.28%
FCF growth 1Y-5.13%
FCF growth 3Y-8.47%
FCF growth 5Y8.61%
OCF growth 1Y-3.23%
OCF growth 3Y-5.31%
OCF growth 5Y10.49%